ORYZON to provide corporate progress updates at several events in January

by Oryzon Genomics

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...

Read more

Detectan mediante resonancia magnética el daño axonal como biomarcador temprano en pacientes con esclerosis múltiple

by CSIC - Centro Superior de Investigaciones Científicas

Con el objetivo de determinar si el aumento del tamaño de los axones puede ser un biomarcador temprano de la esclerosis múltiple se ha dirigido un estudio en el que han conseguido detectar el daño...

Read more

A study led by the IISPV investigates the influence of walnuts on the child neuropsychological development

by Institut d'Investigació Sanitària Pere Virgili (IISPV)

The Clinical and Epidemiological Neuroscience Research Group (NeuroEpia) of the Pere Virgili Health Research Institute (IISPV) will lead an international project to study the influence of nuts and esp...

Read more

Discovering a defective class of neurons in the brains of individuals with schizophrenia

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The defect in inhibitory neurons causes a distortion of reality in the brains of individuals with schizophrenia and can explain the majority of the symptoms of the disease, both cognitive and emotiona...

Read more

New impulse for research in digital neuroscience

by Universidad Rey Juan Carlos

The European Commission has accepted the EBRAINS 2.0 proposal, granting 38 million euros to continue developing the services of the EBRAINS research infrastructure, focused on the creation of digital ...

Read more

Sant Pau initiates the second clinical trial on the long-term effects of deep brain stimulation (DBS) in patients with ultra-resistant schizophrenia to treatment

by Hospital de la Santa Creu i Sant Pau

The hospital is launching a second scientific study with a group of 6 new patients to analyze the long-term effects of DBS and expand therapeutic targets in the brain. This will further personalize th...

Read more

Innovative graphene-based implantable technology paves the way for high-precision therapeutic applications

by Universitat Autònoma de Barcelona (UAB)

A study published in Nature Nanotechnology presents an innovative graphene-based neurotechnology with the potential for a transformative impact in neuroscience and medical applications.

Read more

A new neuroscientific study paves the way for improving the diagnosis and treatment of Alzheimer’s

by UPF - Universitat Pompeu Fabra

Researchers at the UPF Center for Brain and Cognition (CBC) and the Visualization, Virtual Reality and Graphics Interaction (ViRVIG) research group at the UdG have driven this study, which reveals new...

Read more

La microbiota influye en la inteligencia

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

Un estudio abre la posibilidad al desarrollo de nuevas terapias para mejorar el neurodesarrollo infantil mediante el uso de compuestos o microorganismos probióticos

Read more

ORYZON to provide corporate progress updates at several events in February-March

by Oryzon Genomics

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...

Read more

Investigadores identifican una nueva aplicación de un fármaco para la regeneración de lesiones cerebrales

by Fundación Andaluza para la Divulgación de la Innovación y el Conocimiento

Investigadores de las universidades de Cádiz y Sevilla han identificado que un fármaco, que se utiliza en la actualidad para el tratamiento de cáncer de pulmón, facilita la repoblación con nuevas...

Read more

The UB participates in a project to identify new therapeutic targets for diseases of the central nervous system

by Fundació Bosch i Gimpera

A research team from the University of Barcelona (UB) is taking part in a consortium to develop new therapeutic targets for diseases of the central nervous system, such as neurodegenerative pathologie...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream